Prescription Drug Pricing
Health+Benefits
David Axelrod
On the future of the ACA, prescription drugs, pollsters, and whether Mitch McCon...
January 20, 2021
Health+Benefits
The Compounding Business
Q&A with Tara Thompson, Pharmacist and Vice President of Clinical Services at In...
January 19, 2021
Health+Benefits
Compounding Cost Savings
Q&A with Dhaval Bhanusali, MD, Dermatologist and Founder of Skin Medicinals
January 19, 2021
Podcasts
On the Mic with David Axelrod
The Council's Joel Wood follows up with political analyst David Axelrod for an e...
December 14, 2020
Health+Benefits
Runaway Freight Train
Transparency alone isn’t enough to lower drug costs, but it’s a critical ste...
November 13, 2020
Health+Benefits
COVID-19 Solutions Fast-Tracked
Gilead relinquished its orphan drug status for remdesivir shortly after receivin...
May 31, 2020
Health+Benefits
Out of Reach?
New models for financing and providing rare disease treatment could make for a s...
May 31, 2020
Health+Benefits
Parsing the Drug Supply Chain
Q&A with Eric Levin, CEO of Scripta Insights
April 27, 2020
Health+Benefits
PBGH Drug Formulary Study
Q&A with Lauren Vela, Senior Director of Member Value, Pacific Business Group on...
March 1, 2020
Health+Benefits
Hospitals and Insurers Team Up to Manufacture Generic Drugs
Unlikely advocates support lowering prescription drug costs
February 19, 2020